Source: Feedstuffs
Ceva Animal Health, a global leader in animal health, is expanding its European vaccine manufacturing capabilities with a new facility in Monor, Hungary. This 7,000 sq. m plant, equipped with advanced technologies, will focus on producing fermentation-based multicomponent inactivated vaccines for livestock, enabling the production of over 8 billion vaccine doses annually. Scheduled to begin operations by the end of 2026, the project builds on Ceva’s century-long expertise at its Ceva Phylaxia campus.
The investment underscores Ceva’s commitment to preventive medicine and tailored solutions for emerging diseases and variants. Currently, 54% of its R&D budget supports vaccine development, contributing to the fight against 19 zoonotic diseases and advancing pandemic preparedness. Ceva’s innovations include an mRNA platform for animals and leadership in vector vaccines for poultry. Led by experienced veterinarians, Ceva aims to support farmers worldwide, improve livestock health, and promote animal welfare through cutting-edge research, vaccines, and pharmaceutical solutions.
Read the full story HERE: https://www.feedstuffs.com/agribusiness-news/ceva-to-build-vaccine-manufacturing-plant-in-hungary